Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of biomarkers in monitoring antiblastic cardiotoxicity.
Novo G, Cadeddu C, Sucato V, Pagliaro P, Romano S, Tocchetti CG, Zito C, Longobardo L, Nodari S, Penco M. Novo G, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e27-e34. doi: 10.2459/JCM.0000000000000379. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755240 Review.
Role of biomarkers in monitoring antiblastic cardiotoxicity.
Novo G, Cadeddu C, Sucato V, Pagliaro P, Romano S, Tocchetti CG, Zito C, Longobardo L, Nodari S, Penco M. Novo G, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S27-34. doi: 10.2459/JCM.0000000000000379. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183522 Review.
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies.
Cadeddu C, Mercurio V, Spallarossa P, Nodari S, Triggiani M, Monte I, Piras R, Madonna R, Pagliaro P, Tocchetti CG, Mercuro G. Cadeddu C, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S64-75. doi: 10.2459/JCM.0000000000000382. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183527 Review.
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies.
Cadeddu C, Mercurio V, Spallarossa P, Nodari S, Triggiani M, Monte I, Piras R, Madonna R, Pagliaro P, Tocchetti CG, Mercuro G. Cadeddu C, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e64-e75. doi: 10.2459/JCM.0000000000000382. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755244 Review.
Mediterranean diet impact on cardiovascular diseases: a narrative review.
Mattioli AV, Palmiero P, Manfrini O, Puddu PE, Nodari S, Dei Cas A, Mercuro G, Scrutinio D, Palermo P, Sciomer S, Di Francesco S, Novo G, Novo S, Pedretti RFE, Zito A, Parati G, Pedrinelli R, Farinetti A, Maiello M, Moscucci F, Tenaglia RL, Sucato V, Triggiani M, Cugusi L, Scicchitano P, Saba PS, Ciccone MM. Mattioli AV, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2017 Dec;18(12):925-935. doi: 10.2459/JCM.0000000000000573. J Cardiovasc Med (Hagerstown). 2017. PMID: 28914660 Free article. Review.
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure.
Correale M, Paolillo S, Mercurio V, Limongelli G, Barillà F, Ruocco G, Palazzuoli A, Scrutinio D, Lagioia R, Lombardi C, Lupi L, Magrì D, Masarone D, Pacileo G, Scicchitano P, Matteo Ciccone M, Parati G, Tocchetti CG, Nodari S. Correale M, et al. Among authors: nodari s. Eur J Intern Med. 2020 Jan;71:23-31. doi: 10.1016/j.ejim.2019.10.008. Epub 2019 Nov 8. Eur J Intern Med. 2020. PMID: 31708358 Review.
Direct oral anticoagulants across the heart failure spectrum: the precision medicine era.
Paolillo S, Ruocco G, Filardi PP, Palazzuoli A, Tocchetti CG, Nodari S, Lombardi C, Metra M, Correale M; “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology. Paolillo S, et al. Among authors: nodari s. Heart Fail Rev. 2022 Jan;27(1):135-145. doi: 10.1007/s10741-020-09994-0. Heart Fail Rev. 2022. PMID: 32583229 Review.
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan.
Dini FL, Carluccio E, Bitto R, Ciccarelli M, Correale M, D'Agostino A, Dattilo G, Ferretti M, Grelli A, Guida S, Jacoangeli F, Lupi L, Luschi L, Masarone D, Mercurio V, Pacileo G, Pugliese NR, Rispoli A, Scelsi L, Tocchetti CG, Brunetti ND, Palazzuoli A, Piepoli M, Nodari S, Ambrosio G; Working Group on Heart Failure of the Italian Society of Cardiology. Dini FL, et al. Among authors: nodari s. ESC Heart Fail. 2022 Apr;9(2):1107-1117. doi: 10.1002/ehf2.13779. Epub 2022 Feb 5. ESC Heart Fail. 2022. PMID: 35122477 Free PMC article.
Innovations in medical therapy of heart failure with reduced ejection fraction.
Mercurio V, Ambrosio G, Correale M, Dini FL, Ghio S, Nodari S, Palazzuoli A, Ruocco G, Pedrinelli R, Mercuro G, Filardi PP, Indolfi C, Agostoni P, Tocchetti CG, Paolillo S. Mercurio V, et al. Among authors: nodari s. J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e47-e54. doi: 10.2459/JCM.0000000000001413. Epub 2022 Dec 15. J Cardiovasc Med (Hagerstown). 2023. PMID: 36729606 Review.
220 results